Medications at baseline Patients with microvascular dysfunction had a higher rate of lipid-lowering drugs use (43% vs 33%, p=0.032) and a lower rate of aspirin use (43% vs 52%, p=0.06) (did not reach statistical significance) compared with patients with normal microvascular function.
← all excerpts
Coronary endothelial function testing may improve long-term quality of life in subjects with microvascular coronary endothelial dysfunction.
1
—
—